Organization · Private Equity
Credian Partners
Credian Partners is a private equity firm based in South Korea that specializes in strategic acquisitions, corporate divestitures, and growth capital investments. They focus on companies with stable cash flow and growth potential, including those in financial distress.
Overview
What Credian Partners does
What Credian Partners is
Credian Partners is a private equity firm based in South Korea that specializes in strategic acquisitions, corporate divestitures, and growth capital investments. They focus on companies with stable cash flow and growth potential, including those in financial distress.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Private Equity
- Structured capabilities
- Funder
- Last reviewed
- March 4, 2026
Official channels
Find Credian Partners elsewhere
Open the official website or a supported primary organization account.
Capability profile
Credian Partners as a funder
Investment thesis
Credian Partners focuses on strategic acquisitions and minority interest buyouts across various industries. The firm aims to enhance corporate value through comprehensive analysis and prioritizes investments in resilient sectors with perennial demand.
Focus narrative
Credian Partners invests in various industries through strategic acquisitions and minority interest buyouts. The firm emphasizes cross-border investments and seeks to enhance corporate value through comprehensive analysis. Their investment strategy includes identifying proprietary deals, enhancing value during due diligence, and focusing on small to mid-cap companies that are leaders in their niche markets but underperforming. They prioritize resilient sectors that address perennial demand and structural bottlenecks.
Focus and fit
- Regions
- Asia
Availability
- Currently deploying
- Not published
Portfolio and track record
- Recorded portfolio count
- 5
Portfolio context
Green Cross Biotherapeutics: A Canadian subsidiary of Green Cross, a leading Korean pharmaceutical company. Investment Amount: CAD 70 million. Psomagen: A USA subsidiary of Macrogen, specializing in DNA analysis services. Investment Amount: USD 10 million. WiseUX: Owner of premium frozen chicken breast brands ‘I’m Dak’ and 'I’m Well' in the HMR market. Investment Amount: KRW 23 billion. NuScale Power: Provider of advanced nuclear small modular reactor technology. Investment Amount: USD 20 million. Valuence Merger Corp. I: A Nasdaq SPAC targeting Asian life science and sustainable technology firms. Capital Raised: USD 220 million.
Common questions
What to know about Credian Partners
Upseed classifies Credian Partners under the Private Equity organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 4, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.